Prospective study of the safety, feasibility of bevacizumab in the treatment of radiation injury for children with central nervous system tumors.
Latest Information Update: 02 Dec 2020
At a glance
- Drugs Bevacizumab (Primary)
- Indications Astrocytoma; CNS cancer; Ependymoma; Glioma
- Focus Adverse reactions
- 02 Dec 2020 New trial record